We are getting a lot of questions about Evosep these days, and we are excited that you want to know who we are and what we do. To answer the most asked question and to share our perspectives on clinical proteomics we have conducted four short blog post for you to read.
It has been a pleasure introducing you to who we are. We hope you know us a little better by now, and will enjoy reading about our future thoughts on mass spectrometry-based omics.
Last time we talked about our view on proteomics right now, and today we are introducing you to the Evosep One – a novel separation solution designed for fast and robust separation of omics samples in large clinical cohort studies (primarily proteomics and metabolomics).
Welcome back. It is a great pleasure for us to introduce you to our view on clinical proteomics right now.
Dr. Holms explains how clinical proteomics can impact patient care
